Sitara Peroxide Limited (PSX:SPL)

Sitara Peroxide Statistics

Total Valuation

Sitara Peroxide has a market cap or net worth of PKR 2.01 billion. The enterprise value is 2.41 billion.

Market Cap	2.01B
Enterprise Value	2.41B

Important Dates

The last earnings date was Saturday, February 28, 2026.

Earnings Date	Feb 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Sitara Peroxide has 55.10 million shares outstanding.

Current Share Class	55.10M
Shares Outstanding	55.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	61.39%
Owned by Institutions (%)	n/a
Float	17.45M

Valuation Ratios

The trailing PE ratio is 13.49.

PE Ratio	13.49
Forward PE	n/a
PS Ratio	46,053.35
PB Ratio	1.65
P/TBV Ratio	1.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	16.20
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.33.

Current Ratio	0.35
Quick Ratio	0.06
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.38

Financial Efficiency

Return on equity (ROE) is 12.93% and return on invested capital (ROIC) is -19.77%.

Return on Equity (ROE)	12.93%
Return on Assets (ROA)	-6.72%
Return on Invested Capital (ROIC)	-19.77%
Return on Capital Employed (ROCE)	-21.17%
Weighted Average Cost of Capital (WACC)	1.77%
Revenue Per Employee	3,359
Profits Per Employee	11.46M
Employee Count	13
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-101.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +203.91% in the last 52 weeks. The beta is -0.68, so Sitara Peroxide's price volatility has been lower than the market average.

Beta (5Y)	-0.68
52-Week Price Change	+203.91%
50-Day Moving Average	56.56
200-Day Moving Average	36.91
Relative Strength Index (RSI)	29.48
Average Volume (20 Days)	10,566

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sitara Peroxide had revenue of PKR 43,670 and earned 149.03 million in profits. Earnings per share was 2.70.

Revenue	43,670
Gross Profit	43,670
Operating Income	-300.29M
Pretax Income	47.58M
Net Income	149.03M
EBITDA	-121.88M
EBIT	-300.29M
Earnings Per Share (EPS)	2.70

Balance Sheet

The company has 1.23 million in cash and 404.30 million in debt, with a net cash position of -403.07 million or -7.32 per share.

Cash & Cash Equivalents	1.23M
Total Debt	404.30M
Net Cash	-403.07M
Net Cash Per Share	-7.32
Equity (Book Value)	1.22B
Book Value Per Share	22.08
Working Capital	-801.00M

Cash Flow

Operating Cash Flow	-73.98M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -687,628.88% and 341,267.86%.

Gross Margin	100.00%
Operating Margin	-687,628.88%
Pretax Margin	108,963.86%
Profit Margin	341,267.86%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Sitara Peroxide does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.41%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sitara Peroxide has an Altman Z-Score of -0.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.48
Piotroski F-Score	2